CEO U-turns on plans as patent challenge to key drug sees company guide below analyst expectations for 2019

Irish industry’s chief looks for partnership as he admits trust is lacking

Pharma giant’s Irish experience ‘fantastic’, says chief executive Brent Saunders

Vitae Pharmaceuticals focused on medicines for skin conditions including psoriasis

New rules on corporate inversions see parties turn their attention elsewhere

CEO Brent Saunders sees no obstacles to closing controversial $160bn Pfizer deal later this year

Deal makes Ireland home to the largest pharmaceutical company in the world

CEO warns that any attempt to block a takeover by Pfizer would be a “short-sighted intervention”

No one questioning wisdom of approach or ability of companies to do a deal

Chief executive Brent Saunders insists the move would not be only for tax reasons